These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. TWEAK activation of the non-canonical NF-κB signaling pathway differentially regulates melanoma and prostate cancer cell invasion. Armstrong CL; Galisteo R; Brown SA; Winkles JA Oncotarget; 2016 Dec; 7(49):81474-81492. PubMed ID: 27821799 [TBL] [Abstract][Full Text] [Related]
3. TWEAK/Fn14 interaction induces proliferation and migration in human airway smooth muscle cells via activating the NF-κB pathway. Zhu C; Zhang L; Liu Z; Li C; Bai Y J Cell Biochem; 2018 Apr; 119(4):3528-3536. PubMed ID: 29143982 [TBL] [Abstract][Full Text] [Related]
5. Out of the TWEAKlight: Elucidating the Role of Fn14 and TWEAK in Acute Kidney Injury. Sanz AB; Ruiz-Andres O; Sanchez-Niño MD; Ruiz-Ortega M; Ramos AM; Ortiz A Semin Nephrol; 2016 May; 36(3):189-98. PubMed ID: 27339384 [TBL] [Abstract][Full Text] [Related]
6. Metformin improves relevant disease parameters in an autosomal dominant polycystic kidney disease mouse model. Pastor-Soler NM; Li H; Pham J; Rivera D; Ho PY; Mancino V; Saitta B; Hallows KR Am J Physiol Renal Physiol; 2022 Jan; 322(1):F27-F41. PubMed ID: 34806449 [TBL] [Abstract][Full Text] [Related]
7. TWEAK/Fn14 Is Overexpressed in Crohn's Disease and Mediates Experimental Ileitis by Regulating Critical Innate and Adaptive Immune Pathways. Di Martino L; Osme A; Kossak-Gupta S; Pizarro TT; Cominelli F Cell Mol Gastroenterol Hepatol; 2019; 8(3):427-446. PubMed ID: 31181286 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of suppressor of cytokine signaling 1 mediates the profibrotic effect of TWEAK/Fn14 signaling on kidney cells. Chen J; Jia F; Ren K; Luo M; Min X; Wang P; Xiao S; Xia Y Cell Signal; 2020 Jul; 71():109615. PubMed ID: 32217132 [TBL] [Abstract][Full Text] [Related]
10. Endogenous concentrations of ouabain act as a cofactor to stimulate fluid secretion and cyst growth of in vitro ADPKD models via cAMP and EGFR-Src-MEK pathways. Jansson K; Nguyen AN; Magenheimer BS; Reif GA; Aramadhaka LR; Bello-Reuss E; Wallace DP; Calvet JP; Blanco G Am J Physiol Renal Physiol; 2012 Oct; 303(7):F982-90. PubMed ID: 22859406 [TBL] [Abstract][Full Text] [Related]
11. The lonidamine derivative H2-gamendazole reduces cyst formation in polycystic kidney disease. Sundar SV; Zhou JX; Magenheimer BS; Reif GA; Wallace DP; Georg GI; Jakkaraj SR; Tash JS; Yu ASL; Li X; Calvet JP Am J Physiol Renal Physiol; 2022 Oct; 323(4):F492-F506. PubMed ID: 35979967 [TBL] [Abstract][Full Text] [Related]
12. Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease. Chen L; Zhou X; Fan LX; Yao Y; Swenson-Fields KI; Gadjeva M; Wallace DP; Peters DJ; Yu A; Grantham JJ; Li X J Clin Invest; 2015 Jun; 125(6):2399-412. PubMed ID: 25961459 [TBL] [Abstract][Full Text] [Related]
13. HL156A, an AMP-Activated Protein Kinase Activator, Inhibits Cyst Growth in Autosomal Dominant Polycystic Kidney Disease. Seo S; Kim H; Hwang JT; Kim JE; Kim J; Jeon S; Song YJ; Choi KH; Sim G; Cho M; Yoon JW; Kim H Biomolecules; 2024 Jul; 14(7):. PubMed ID: 39062520 [TBL] [Abstract][Full Text] [Related]
14. Cardamonin retards progression of autosomal dominant polycystic kidney disease via inhibiting renal cyst growth and interstitial fibrosis. He J; Zhou H; Meng J; Zhang S; Li X; Wang S; Shao G; Jin W; Geng X; Zhu S; Yang B Pharmacol Res; 2020 May; 155():104751. PubMed ID: 32151678 [TBL] [Abstract][Full Text] [Related]
15. Inhibiting the HSP90 chaperone slows cyst growth in a mouse model of autosomal dominant polycystic kidney disease. Seeger-Nukpezah T; Proia DA; Egleston BL; Nikonova AS; Kent T; Cai KQ; Hensley HH; Ying W; Chimmanamada D; Serebriiskii IG; Golemis EA Proc Natl Acad Sci U S A; 2013 Jul; 110(31):12786-91. PubMed ID: 23858461 [TBL] [Abstract][Full Text] [Related]
16. Ablation of Long Noncoding RNA Hoxb3os Exacerbates Cystogenesis in Mouse Polycystic Kidney Disease. Weisser I; Eckberg K; D'Amico S; Buttram D; Aboudehen K J Am Soc Nephrol; 2024 Jan; 35(1):41-55. PubMed ID: 37953472 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of the TWEAK/Fn14 pathway attenuates renal disease in nephrotoxic serum nephritis. Xia Y; Campbell SR; Broder A; Herlitz L; Abadi M; Wu P; Michaelson JS; Burkly LC; Putterman C Clin Immunol; 2012 Nov; 145(2):108-21. PubMed ID: 22982296 [TBL] [Abstract][Full Text] [Related]
18. Tweak/Fn14 system is involved in rhabdomyolysis-induced acute kidney injury. Guerrero-Hue M; Vallejo-Mudarra M; García-Caballero C; Córdoba-David GM; Palomino-Antolín A; Herencia C; Vendrell-Casana B; Rubio-Navarro A; Egido J; Blanco-Colio LM; Moreno JA Biomed Pharmacother; 2023 Dec; 169():115925. PubMed ID: 38007933 [TBL] [Abstract][Full Text] [Related]
19. A major role of TWEAK/Fn14 axis as a therapeutic target for post-angioplasty restenosis. Méndez-Barbero N; Gutierrez-Muñoz C; Madrigal-Matute J; Mínguez P; Egido J; Michel JB; Martín-Ventura JL; Esteban V; Blanco-Colio LM EBioMedicine; 2019 Aug; 46():274-289. PubMed ID: 31395500 [TBL] [Abstract][Full Text] [Related]
20. Extracellular vesicles and exosomes generated from cystic renal epithelial cells promote cyst growth in autosomal dominant polycystic kidney disease. Ding H; Li LX; Harris PC; Yang J; Li X Nat Commun; 2021 Jul; 12(1):4548. PubMed ID: 34315885 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]